Droplet Microfluidics

ANNA MACDONALD | March 21, 2018

article image
Droplet microfluidics enables the manipulation of discrete fluid packets in the form of microdroplets and has a variety of real-world applications. How microdroplets are generated. Some of the advantages they offer over the conventional microfluidics. How they are used in a variety of applications ranging from droplet digital PCR to 3D cell culture.

Spotlight

Bioarray Genetics

Bioarray Genetics is a biotech company located in New Haven, Connecticut. We are committed to transforming cancer treatment decisions and outcomes using gene profiling to provide clinically actionable results to clinicians and patients.

OTHER ARTICLES

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | March 1, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | March 1, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | March 1, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Spotlight

Bioarray Genetics

Bioarray Genetics is a biotech company located in New Haven, Connecticut. We are committed to transforming cancer treatment decisions and outcomes using gene profiling to provide clinically actionable results to clinicians and patients.

Events